Browse Category

Customs Expert

ACEBest PracticesCustoms ExpertImportInternational TradePre-complianceReasonable CareU.S. Customs and Border Protection (CBP)

ACE: Auditing Your Import History

posted by Jennifer Diaz May 11, 2021 0 comments

In FY 2020 alone, U.S. Customs and Border Protection (“CBP”) import audits resulted in over $44.6 million being collected by CBP. Similarly, CBP collected over $20.1 million in FY 2020 from trade-related penalties and liquidated damages. Prior to CBP auditing you, there is a lot you can do to be proactive about import compliance. The first step is getting a clear picture of your imports by accessing and analyzing your import data on the Automated Commercial Environment (“ACE”). An ACE  audit can identify duty-saving opportunities and open risks.

To date, CBP has collected $87.8 billion in China 301 tariffs. If you have paid Section 301 China tariffs on Lists 3 and 4 and you have joined the landmark lawsuit demanding full refunds on these tariffs paid, it is critical that you understand the extent of China tariffs that you have paid, and proactively look out for liquidations. Proactively and comprehensively auditing your ACE import data is the first step.

Whether you are new to importing or a seasoned professional, this one-hour webinar is a must attend. Register today to hear directly from our Diaz Trade Law President Jennifer (Jen) Diaz about audit risks and duty-saving opportunities. Jen is a Chambers ranked, Board Certified International Attorney specializing in customs and international trade.

Continue Reading

Best PracticesChina Trade WarCustoms ExpertEnforcementExportImportInternational BusinessInternational LawInternational TradeU.S. Customs and Border Protection (CBP)U.S. Trade Representative (USTR)

An Introduction to Safeguard Investigations

posted by Jennifer Diaz May 6, 2021 0 comments

What is Section 201 ?

Section 201 of the Trade Act of 1974 provides import relief measures (also known as Safeguards) for domestic industries. The measures provide temporary relief for U.S. industries when competitor imports increase so significantly that they cause serious injury or threat to the domestic industry. The Safeguard measures are temporary – they allow the U.S. President to raise import duties or impose nontariff barriers on goods entering the United States for a limited period so that domestic industry is given sufficient time to adjust to the competition.

Continue Reading

ACEBest PracticesCounterfeitsCTPATCurrency SeizureCustoms BrokerCustoms ExpertEnforcementForced LaborFreight ForwardingHTSICEImportInternational BusinessInternational LawInternational TradeIPR, Trademarks and LogosLabelingLabor RightsPenaltyPre-complianceReasonable CareSeizuresSpeakingSupply ChainU.S. Customs and Border Protection (CBP)U.S. Department of Homeland Security (DHS)

REGISTER TODAY! NEI Accredited Webinar Importing 101 – Introduction to U.S. Customs

posted by Jennifer Diaz April 28, 2021 0 comments

Webinar Importing 101 Introduction to US CustomsCo-Authored by Denise Calle

Whether you are new to importing or seasoned, this one-hour webinar is a must attend. Register today to hear directly from this specialized, expert trio on the “Top 10 Tips When Importing to Ensure Compliance” with real case studies:

Continue Reading

301 INVESTIGATIONSBest PracticesChinaChina Trade WarCOVID-19Customs ExpertEnforcementHTSImportInternational BusinessInternational TradeSpecial 301Trade PolicyU.S. Customs and Border Protection (CBP)U.S. Trade Representative (USTR)

301 Exclusion Extensions for COVID-19 Related Products

posted by Jennifer Diaz April 13, 2021 0 comments

On March 10, 2021, via Federal Register Notice ( 86 FR 13785), the United States Trade Representative (USTR) announced that 99 medical product exclusions will be extended from March 31, 2021, to September 30, 2021. This action extends a previous USTR action which extended these exclusions from December 31, 2020, to March 31, 2020 (85 FR 85831). Continue Reading

Best PracticesCustoms ExpertEnforcementExportInternational BusinessInternational LawInternational TradePre-complianceU.S. Food and Drug Administration (FDA)

OTC Drug Manufacturers are Required to Pay FDA Facility User Fees by May 10, 2021

posted by Jennifer Diaz April 8, 2021 0 comments

Co-Authored by Denise Calle.

On March 26, 2021, Food and Drug Administration (FDA) published the Federal Register Notice, “Fee Rates Under the Over-the-Counter Monograph Drug User Fee Program for Fiscal Year 2021,” announcing the OTC Monograph Drug user fee program fee rates for FY 2021. This is the first year FDA has expanded user fees to OTC Drug Manufacturers and submitters of OTC monograph order requests.

Continue Reading

Best PracticesChinaChina Trade WarCustoms ExpertEnforcementExportImportImport AlertInternational BusinessInternational LawInternational Trade

Future of First Sale Rule in Question

posted by Jennifer Diaz April 6, 2021 0 comments

On March 1, 2021, the Court of International Trade (CIT) denied Meyer Corporation’s claim for duty-free treatment under its attempted use of the first sale valuation and the Generalized System of Preferences (GSP), in Meyer Corporation, U.S. v. United States, Court No. 13-00154 (Meyer). This case sent a ripple through the trade-community as many speculate whether the decision signals an end of first sale for non-market countries.

Continue Reading

AD/CVDBest PracticesChina Trade WarCustoms ExpertEnforcementExportImportInternational LawInternational TradeU.S. Customs and Border Protection (CBP)

New AD/CVD Petition Against Imports of Certain Chinese Mobile Access Equipment

posted by Jennifer Diaz March 25, 2021 0 comments

Co-Authored by Sharath Patil

Background on AD/CVD Investigations

Antidumping duty (“AD”) and countervailing duty (“CVD”) investigations are brought jointly by the U.S. International Trade Commission (“USITC”) and the U.S. Department of Commerce (“Commerce”). AD investigations are triggered when a domestic industry alleges that it has been injured by competing imports of particular goods from specific countries being sold at less than a fair value. Meanwhile, CVD investigations are triggered when a domestic industry alleges that it has been injured by competing imports that are being unfairly subsidized by their governments. The domestic industry initiating the investigation is known as the petitioner while the foreign industry participating in the investigation is known as the respondent.

Continue Reading

Customs BrokerCustoms ExpertEnforcementImport AlertInternational BusinessInternational LawInternational TradeU.S. Customs and Border Protection (CBP)

Breaking News – New Federal Law Expands Furniture Flammability Testing Standard

posted by Jennifer Diaz March 23, 2021 0 comments

Do you manufacture or sell upholstered furniture? Beginning June 25, 2021, a new law requires all upholstered furniture nationwide to comply with California Technical Bulletin 117-2013?

Continue Reading

Best PracticesChina Trade WarCustoms ExpertEnforcementExportImport AlertInternational BusinessInternational LawInternational TradeU.S. Customs and Border Protection (CBP)

Recent Government Data Indicates that Florida Trade is Rebounding Fast Despite Pandemic Hit

posted by Jennifer Diaz March 17, 2021 1 Comment

Co-Authored by Sharath Patil

COVID-19’s Impact on the Global Economy

The COVID-19 pandemic has had systemic implications for nearly every facet of our lives and society. The world of international trade is certainly no exception. Businesses and governments alike have had to figure out how to continue import and export operations while accounting for the risks present in the current trading climate. Challenges that importers and exporters have faced include: 1) dramatic demand spikes for certain goods, 2) equally dramatic crashes in demand for other goods, 3) significant back-ups of inflowing shipments at key ports, 4) an increase in trade restrictions and other barriers to trade, and 5) contractions in trade volumes, just to name a few.

Continue Reading

Best PracticesCustoms ExpertEnforcementEventsInternational LawInternational TradeLabelingU.S. Food and Drug Administration (FDA)

Cleaning for COVID-19 – Importing Cleaning Products: Who Regulates You?

posted by Jennifer Diaz March 15, 2021 0 comments

Co-Authored by Denise Calle

A year into the COVID-19 pandemic, the U.S. Environmental Protection Agency (EPA) and The Food and Drug Administration (FDA) are in full enforcement mode carefully monitoring novel products claiming to treat, mitigate, or “kill” COVID-19. Compliance advisories issued at the beginning of the pandemic are now being replaced with enforcement advisories. Manufacturers, importers, distributors, and others engaged in the production or sale of products claiming to mitigate or “kill” COVID-19 should be more cautious than ever when developing product claims for both product labels and marketing material or alternatively, confirm products comply with the numerous regulations governing COVID-19 cleaning products.

Continue Reading